Bide Pharmatech Co. Ltd. A (688073) — Cash Flow Quality Index
Bide Pharmatech Co. Ltd. A (688073) has a Cash Flow Quality Index of 0.19x as of December 2025. Operating cash flow of CN¥28.32 Million is below net income of CN¥151.74 Million, suggesting accrual-heavy earnings not yet converted to cash. Also explore Bide Pharmatech Co. Ltd. A asset portfolio for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Bide Pharmatech Co. Ltd. A Cash Flow Quality Index (2020–2025)
Historical Cash Flow Quality Index for Bide Pharmatech Co. Ltd. A across 6 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 688073 tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Bide Pharmatech Co. Ltd. A (2020–2025)
Year-by-year earnings quality comparison for Bide Pharmatech Co. Ltd. A. For live market cap and the full company financial profile, see Bide Pharmatech Co. Ltd. A stock valuation.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.19x | CN¥28.32 Million | CN¥151.74 Million | ▼ -86.2% |
| 2024 | 1.35x | CN¥158.31 Million | CN¥117.43 Million | ▲ +357.4% |
| 2023 | -0.52x | CN¥-57.39 Million | CN¥109.57 Million | ▼ -355.9% |
| 2022 | 0.20x | CN¥29.87 Million | CN¥145.97 Million | ▲ +130.8% |
| 2021 | -0.66x | CN¥-64.88 Million | CN¥97.57 Million | ▼ -1176.4% |
| 2020 | 0.06x | CN¥3.65 Million | CN¥59.00 Million | — |